FP
LLY icon

Factorial Partners’s Eli Lilly LLY Stock Holding History

Factorial Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6,300
Closed -$729K – 136
2018
Q4 		$729K Hold
6,300
– – 0.76% 42
2018
Q3 		$676K Sell
6,300
-28,500
-82% -$2.85M 0.58% 63
2018
Q2 		$2.97M Sell
34,800
-5,300
-13% -$435K 2.65% 7
2018
Q1 		$3.1M Buy
+40,100
New +$3.23M 2.83% 5

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Factorial Partners's LLY Position: Q1 2019 in Review

Factorial Partners sold out of Eli Lilly (LLY) in Q1 2019, closing a stake of 6,300 shares — an estimated $729K sold.

Factorial Partners first reported a position in LLY in Q1 2018 and held it in 4 quarters. The position peaked at $3.1M in Q1 2018. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

  • Factorial Partners reported no remaining Eli Lilly position as of Q1 2019 after selling out during the quarter.
  • Factorial Partners sold 6,300 Eli Lilly shares in Q1 2019, an estimated $729K.
  • Factorial Partners first reported a position in Eli Lilly in Q1 2018 and held it in 4 quarters.
  • Factorial Partners's Eli Lilly position peaked at $3.1M in Q1 2018.
  • 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on Factorial Partners's 13F filing for Q1 2019, filed 10 May 2019.